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The question whether mixture effects are
additive cannot be answered without infor-
mation on the dose–response relationship for
the single agents. Figure 1 (left) illustrates the
problem. Assume that dose level x of sub-
stance A produces response level y. If sub-
stance B is added at a dose level that also
produces response level y, and the combined
exposure results in a response level >>2y, one
is tempted to call this a supra-additive combi-
nation effect. However, this result could sim-
ply be the consequence of a sublinear
dose–response relationship for the single sub-
stances; that is, dose level 2x of A would on
its own result in response level >>2y.
Therefore, the response obtained with the
combination treatment is not the result of an
interaction. It is still additive.
Figure 1 (right) illustrates the situation in
more general terms. It shows different
responses when increasing doses of chemical B 
are added to a ﬁxed dose x of A. If B acts by
“simple joint action” as originally termed by
Bliss (1), the combined response follows the
“curve of joint action.” This is also called
“dose addition” and indicates the same mode
of action of the two chemicals. On the other
hand, if B produces the same type of response
but by a mechanism unrelated to A, the
“curve of independent action” is followed.
Based on this concept, all data points
between the two curves lie on the “surface of
additivity.” This issue was taken up long ago
in radiobiology under the concept of “isoad-
dition,” heteroaddition, and the “envelope of
additivity” (2–5). In chemical mixture toxi-
cology, it has not gained much attention.
For numerous end points of toxicity (e.g.,
carcinogenicity), sublinear dose–response 
relationships are not uncommon (6). This
can be explained by superimposition of vari-
ous effects that modulate or contribute to the
process of cancer formation (7). For instance,
DNA repair processes can become saturated
with increasing doses of a genotoxic carcino-
gen, or cytotoxicity at high doses can result
in regenerative processes that accelerate the
conversion of primary DNA lesions to 
mutations. Furthermore, cell death elicits an
immune reaction that can be associated with
oxidative stress, which in turn can result in
an increased level of indirect, oxygen-related
DNA damage in surviving neighbor cells (7).
For genotoxic carcinogens, therefore,
dose–response linearity could only be postu-
lated for situations in which the effect is
dominated by one single mode of action
such as DNA adduct formation. At higher
doses, saturation phenomena and additional
mechanisms result in deviation from 
linearity.
Environmental exposure of humans is
usually in a low-dose range, in most situa-
tions below the lowest observable effect level
(LOEL). The best approach, therefore, to
avoid confounding by nonlinear shapes of
the dose response is to work at the limit of
detection of a toxic response. This has the
additional advantage that the number of
experiments can markedly be reduced. If
high dose levels are to be included in the
evaluation of mixture effects, for instance, if
there is interest in accidentally high exposure
levels or in pharmacological combination
treatments, it will be necessary to investigate
the full dose–response relationship for the
single agents.
The suggested procedure to investigate
deviation from additivity at the LOEL is as
follows:
• Determine (or take from literature data) an
approximate LOEL for the agents to be
tested in combination.
• Divide each LOEL by the number of agents
to be combined (n).
• Measure the effect of the combination of n
agents each at LOEL/n.
• Analyze the result for the signiﬁcance of an
interaction term by n-factor analysis of
variance.
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Chemical Mixtures
Sublinear dose–response relationships are often seen in toxicity testing, particularly with bioassays
for carcinogenicity. This is the result of a superimposition of various effects that modulate and
contribute to the process of cancer formation. Examples are saturation of detoxiﬁcation pathways
or DNA repair with increasing dose, or regenerative hyperplasia and indirect DNA damage as a
consequence of high-dose cytotoxicity and cell death. The response to a combination treatment
can appear to be supra-additive, although it is in fact dose-additive along a sublinear
dose–response curve for the single agents. Because environmental exposure of humans is usually in
a low-dose range and deviation from linearity is less likely at the low-dose end, combination
effects should be tested at the lowest observable effect levels (LOEL) of the components. This
principle has been applied to combinations of genotoxic agents in various cellular models. For sta-
tistical analysis, all experiments were analyzed for deviation from additivity with an n-factor analy-
sis of variance with an interaction term, n being the number of components tested in
combination. Benzo[a]pyrene, benz[a]anthracene, and dibenz[a,c]anthracene were tested at the
LOEL, separately and in combination, for the induction of revertants in the Ames test, using
Salmonella typhimurium TA100 and rat liver S9 fraction. Combined treatment produced no devi-
ation from additivity. The induction of micronuclei in vitro was investigated with ionizing radia-
tion from a 137Cs source and ethyl methanesulfonate. Mouse lymphoma L5178Y cells revealed a
signiﬁcant 40% supra-additive combination effect in an experiment based on three independent
replicates for controls and single and combination treatments. On the other hand, two human
lymphoblastoid cell lines (TK6 and WTK1) as well as a pilot study with human primary ﬁbrob-
lasts from fetal lung did not show deviation from additivity. Data derived from one cell line
should therefore not be generalized. Regarding the testing of mixtures for deviation from additive
toxicity, the suggested experimental protocol is easily followed by toxicologists. Key words: 137Cs,
Ames test, cell line, chemically induced, dose–response relationship, drug effects, drug interac-
tions, ethyl methanesulfonate, gamma rays, genotoxicity, L5178Y, micronuclei, models, muta-
gens, polynuclear aromatic hydrocarbons, radiation effects, research design, risk assessment,
statistics, TK6, WTK1. Environ Health Perspect 110(suppl 6):915–918 (2002).
http://ehpnet1.niehs.nih.gov/docs/2002/suppl-6/915-918lutz/abstract.html
Deviation from Additivity in Mixture Toxicity: Relevance of
Nonlinear Dose–Response Relationships and Cell Line Differences in
Genotoxicity Assays with Combinations of Chemical Mutagens and
γ-Radiation
Werner K. Lutz,1 Spyros Vamvakas,1 Annette Kopp-Schneider,2 Josef Schlatter,3 and Helga Stopper1
1Department of Toxicology, University of Würzburg, Würzburg, Germany; 2Biostatistics Unit, German Cancer Research Center,916 VOLUME 110 | SUPPLEMENT 6 | DECEMBER 2002 • Environmental Health Perspectives
In the case of additivity, the response to the
combination treatment should just produce
the lowest observable effect in the assay.
We used this type of approach first to
investigate the combined mutagenicity of three
mutagens with similar mode of action, the
polynuclear aromatic hydrocarbons (PAHs)
benzo[a]pyrene (B[a]P), benz[a]anthracene
(B[a]A), and dibenz[a,c]anthracene (DB[ac]A),
in the Ames test using Salmonella typhimurium
tester strain TA100. For the second part, the
DNA alkylating agent ethyl methanesulfonate
(EMS) and γ-radiation from a 137Cs source
were applied and investigated for the induction
of micronuclei in different cellular eukaryotic
model systems of mouse and human origin.
Although the initial modes of action of these
two genotoxic agents are different, both lead to
the formation of DNA strand breaks and chro-
mosomal breaks.
Materials and Methods
All compounds, media, and stains were from
Sigma (Taufkirchen, Germany). L5178 mouse
lymphoma cells were supplied by W.J. Caspary
(National Institute of Environmental Health
Sciences, Research Triangle Park, North
Carolina, USA). Human cell lines TK6 and
WTK1 were purchased from ATCC
(Manassas, Virginia, USA). Human ﬁbroblasts
were provided by the Department of Human
Genetics, University of Würzburg, Germany.
Ames Test with Combinations 
of Three PAHs
As an approximate LOEL, we used the dose
resulting in a doubling of the background
numbers of revertants. The corresponding
doses for TA100 were taken from the litera-
ture (8) as 0.3, 3, and 0.3 µg/plate, for B[a]P,
B[a]A, and DB[ac]A, respectively.
Treatment solutions were prepared sepa-
rately for each dose level by weighing the
appropriate amount of chemical and dissolv-
ing it in dimethylsulfoxide (DMSO).
Dilutions were prepared to obtain the
required dose in 20 µL DMSO per plate. For
the combination experiments, appropriate
amounts of the three chemicals were weighed,
and the combined portions were dissolved and
diluted in DMSO to a ﬁnal volume of 20 µL
per plate. Salmonella cultures were grown
overnight for approximately 10 hr and had
cell titers of 3–4 × 109/mL. Liver 9,000×g
supernatant (S9; protein concentration, 50
mg/mL) from Arochlor 1254–induced male
Wistar rats and S9 mix containing 5% S9
and an NADPH-regenerating system were
prepared. A modification of the plate incor-
poration test was used (9). We added 100 µL
bacterial suspension, 20 µL DMSO contain-
ing the test compound(s), and 2 mL top agar
containing histidine and biotin to vials pre-
ﬁlled with 500 µL S9 mix. Components were
mixed and plated on Vogel-Bonner medium
E with 1.5% Bacto-Difco agar and 2% glu-
cose. After 2 days of incubation, revertant
colonies were counted with an automated
colony counter. Counts were corrected for
overlapping colonies with a computer pro-
gram. The number of replicates was n = 6 for
the controls, n = 3 for the single agents, and
n = 2 and 4 for the combination experiment
at one-third and one “doubling dose,”
respectively.
In Vitro Micronucleus Test
Cells used were L5178Y mouse lymphoma
cells, the lymphoblastoid human cell line
TK6, the lymphoblastoid human cell line
WTK1, and fibroblasts from lung tissue of
16-week-old human fetus. The method used
for the in vitro micronucleus test using the
L5178Y mouse lymphoma cells and the
respective results have been described previ-
ously (10). In short, treatment included irra-
diation of the cells from a 137Cs source
(662 keV γ-radiation; dose rate, 0.6 or
1 Gy/min), immediately followed by incuba-
tion with EMS. After 4 hr, fresh medium was
added, and the cells were incubated for 15 hr
(30 hr for the human cell lines). Cells were
put on glass slides and fixed with methanol,
and DNA was stained with Hoechst 33258.
As a modification used for the main
experiment with the mouse cells and for all
experiments with the human cells, the
inhibitor of cytokinesis cytochalasin B was
added with the medium change, and acridine
orange was used for staining. Cytochalasin B
allows the cell to replicate the DNA and form
two nuclei but not to form two cells. Scoring
of micronuclei only in binucleated cells
allowed us to restrict the analysis to cells that
have undergone one cycle of DNA replica-
tion. This controls for effects of the treat-
ments on the cell cycle.
Pilot studies were performed with all cell
lines to investigate the low-dose linear response
range. Doses that resulted in a doubling of the
control values were chosen for the main experi-
ments. No deviation from linearity was seen at
this dose level in any cell line. It has to be
noted, however, that background response and
susceptibility of the cells to a doubling dose of
the mutagens changed from cell batch to cell
batch, such that responses usually ranged
within a factor of 1.5–3 of the controls. For
the main experiments, the number of indepen-
dent replicates was n = 3, except for the mouse
lymphoma cells treated with 0.5 Gy alone (one
sample lost), for which n = 2.
Statistical Evaluation of Deviation
from Additivity
For the testing of a putative supra-additive or
subadditive effect of the combination treat-
ment, the data were evaluated with an n fac-
tor analysis of variance with interaction, n
being the number of agents tested in combi-
nation. For the Ames test data with n = 3
chemicals, for instance, the underlying model
is described by the equation y = ctr + a + b + c
+ d + e, where y are the observed numbers of
revertants; ctr is the expected value for the
background revertants; a, b, and c are the
expected effects of the single chemicals; d is
the interaction term for the simultaneous
administration of the three chemicals,
describing the additional positive or negative
effect obtained by simultaneous administra-
tion. Hence, the expected number of rever-
tants for the simultaneous administration of
the chemicals is ctr + a + b + c + d; e is the
error term, accounting for the variation
within groups. The error is assumed to have a
normal distribution with mean 0 and identi-
cal standard deviation for all treatment
groups. The p-value is reported for the test of
the hypothesis that d = 0. It describes the
probability that the observed difference
between the effect of the mixture and the
sum of the single net effects (=additivity) is
different from zero by chance alone. For 
n = 2, this analysis is available in most basic
statistics software. More elaborate software
also allows for n > 2.
Note that for situations with significant
nonlinearity in the dose response for the single
agents, the above analysis is not appropriate.
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Figure 1. Schematic representation of a sublinear dose–response relationship for agent A (left) and two
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Higher-order terms must be introduced and
combination effects analyzed by testing for
interaction of the higher-order terms.
Results
Ames Test with Combinations 
of Three PAHs
Results are shown in Figure 2. The solvent
background derived from six replicates was
170 ± 26 revertants per plate. The doubling
dose considered to represent an LOEL for
the Ames test resulted in slightly more than a
doubling of the background number of
revertants for B[a]P (382) and DB[ac]A
(407) but was only about 1.5-fold for B[a]A
(262). At one-third of the doubling dose, the
net increase was 28–32% of the effect at the
doubling dose, indicating a linear dose
response in this dose range. For B[a]P and
DB[ac]A, the increase was still statistically
significant (p < 0.05). Treatment with the
combination of the three mutagens produced
the result shown by the dark gray bars; the
calculated additivity is represented with the
dark blue bars. No deviation from additivity
was observed.
Induction of Micronuclei in
Eukaryotic Cells by γ-Radiation 
and EMS
Mouse lymphoma cells L5178Y. A dose-ﬁnd-
ing study with up to 400 µg/mL EMS or 
2 Gy showed no deviation from a linear dose
response (10). Various combinations of EMS
and γ-radiation within that dose range
(100–400 µg EMS/mL plus 0.25–1 Gy)
reproducibly showed supra-additivity (10).
An additional experiment performed with the
cytochalasin B modification is shown in
Figure 3 (left). Supra-additivity by 40% was
statistically significant (p = 0.02), using the
two-factor analysis of variance with an inter-
action term as described.
Human cell lines TK6 and WTK1. In
view of the results with the mouse lymphoma
cells, the question was whether the observed
supra-additivity for the induction of micronu-
clei by ionizing radiation and an ethylating
agent was a general phenomenon or whether
it was speciﬁc for a mouse cell line that har-
bors a mutation in the p53 tumor suppressor
gene (11). The lymphoblastoid human cell
line TK6 (12), which does not have a p53
mutation (13), was tested. Pilot experiments
showed a linear dose response up to 1 Gy and
200 µg/mL EMS (data not shown).
Combination treatment with 0.125 Gy and
25 µg/mL EMS did not result in a deviation
from additivity (Figure 3, center). If at all, a
putative deviation would be subadditive.
For the investigation of whether the dif-
ference between the mouse lymphoma cells
and the human TK6 cell line was because of
the difference in the p53 status, the related
human cell line WTK1 (14), which does
have a mutation in the p53 gene (13), was
used. After checking for dose–effect linearity
(data not shown), the main experiment with
0.15 Gy and/or 50 µg/mL EMS was per-
formed. The results are shown in Figure 2
(right). No deviation from additivity was
seen. Again, if there was a deviation at all, it
would be subadditive.
Human primary fibroblasts. One prob-
lem when using cell lines is that they have
lost mortality. The genomic changes asso-
ciated with this feature might have been
responsible for deviation from additivity in
the mouse lymphoma cells. Therefore,
“normal” human cells should be investi-
gated. The results of a pilot study with
fetal human fibroblasts treated with 1 Gy
137Cs irradiation and/or 200 µg/mL EMS
are shown in Table 1. There was no indi-
cation of a deviation from additivity.
Subsequent experiments confirmed this
finding (15).
Discussion
The basic understanding of the toxicology of
chemical mixtures was described more than
60 years ago (1). A recent review gives a
comprehensive overview on the various con-
cepts, experimental strategies, data analyses,
and risk assessment procedures that have
been suggested (16). Still, there appears to be
a lack of simple experimental guidelines. The
present contribution is an attempt in this
direction. The first point addressed, the
problem of nonlinear dose–response relation-
ships, has been a point of concern, and the
idea to focus on a dose range near the limit
of detection has been put forward before
(17). Also, statistical procedures that include
information on the dose–response relation-
ship of the individual components have been
suggested (18,19). Our approach combines
the two issues with an experimental protocol
that is easily followed by toxicologists.
LOEL for the Ames Test at the
Doubling Dose?
In view of the relative ease in performing an
Ames test, numerous mixture studies have
been performed before, but none so far have
included dose levels below the doubling dose.
The present results did not indicate any devia-
tion from additivity. This was not surprising,
however, in view of the same mode of muta-
genic action of B[a]P, B[a]A, and DB[ac]A,
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Table 1. Induction of micronuclei in human primary
fibroblasts by treatment with ionizing radiation
from a 137Cs source and EMS, individually and in
combination (pilot study with duplicates).
MN-cells per
1000 BN-cells Net
Treatment (duplicates) Mean increase
Controls 19 20 19.5
γ-Irradiation (1 Gy) 118 119 118.5 99
EMS (200 µg/mL) 25 29 27 7.5
Sum of net increases
of individual 
treatments 106.5
Combination 
treatment 131 116 123.5 104
Abbreviations: BN-cells, binucleated cells; MN-cells,
micronuclei-containing binucleated cells.based on the formation of DNA adducts of
similar type. Additivity had been observed
before, in connection with spiking diesel
exhaust particle extracts with PAHs (20).
As a byproduct, the present study shed
some light on the rule of thumb that the low-
est observable effect in the Ames test is a dou-
bling of the control number of revertants.
This simple and convenient rule is still
regarded by many as the lowest acceptable
sign of mutagenicity (21). It is often applied
together with the requirement of a dose-
dependent response to keep the number of
false-positive results low. Although this crite-
rion might be appropriate in terms of biologi-
cal relevance, it is hardly acceptable from a
statistical point of view. Based on the data
presented here, it appears that the limit of
detection could be lower by a factor of almost
3 for the strain TA100 and when based on
three independent replicates.
Combined Exposure to Radiation and
Chemicals
Annex H of the UNSCEAR 2000 Report (5)
is an in-depth discussion of “combined effects
of radiation and other agents” and includes
an extensive reference list. A review that
focuses on human health risks is also available
(22). Examples of “synergism” outnumber
observations of additivity or antagonism. This
might in part be the result of nonlinear
dose–response relationships when including
the high dose levels of exposures at the work-
place, in accidents, and from therapeutic pro-
cedures. The UNSCEAR Report states:
In general, for short exposures to high concentra-
tions and for low chronic concentrations, devia-
tions from additivity are small, if at all existent. In
most epidemiological and experimental studies,
effects exceeding a level predicted from isoaddi-
tion have not speciﬁcally been demonstrated. (5)
Indeed, recent experimental studies rarely
show deviation from additivity. This includes
the effects of the tobacco-related nitrosamine
4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone in combination with α-particle
radiation in a human–hamster hybrid cell
assay for toxicity and mutagenicity (23) or
the combined effects of γ-radiation and ethyl-
ene oxide in human diploid ﬁbroblasts (24).
The induction of micronuclei in polychro-
matic erythrocytes of bone marrow of mice
also was additive for the combination of X
rays with cyclophosphamide or mitomycin C
(25). An example for synergistic effects
induced by the combination of an activation-
independent alkylating agent with X rays is
the induction of mutation in the Tradescantia
stamen-hair system (26).
Cell Line Differences
The difference between the mouse lymphoma
cells and the human cell lines could be due to
species differences, the mutation in the p53
gene, or additional mutations in the mouse
cell line (15). Species differences were indi-
cated by the background number of micronu-
cleus-containing cells and the susceptibility to
the mutagens. Although 0.5 Gy and/or 400
µg/mL EMS were required with the mouse
cells, dose levels lower by a factor of 3–16
were sufﬁcient for a comparable effect in the
human cells.
Although no difference between the
human lymphoblastoid cell lines TK6 (nor-
mal p53) and WTK1 (mutant p53) in the
response to the combination treatment was
observed in the present study, folate defi-
ciency interacted significantly with EMS for
the induction of hypoxanthine–guanine
phosphoribosyltransferase mutations in the
same two cell lines (27). This illustrates again
that any result of a mixture effect in a cellular
model may be not only species specific and
cell-type speciﬁc but also agent speciﬁc.
Conclusions
• Combination experiments should be per-
formed at the limit of detection of a toxic
effect. First, “low dose” is as close as possi-
ble to most environmental human exposure
levels; second, the danger of a nonlinear
dose response for the single agents (which
could result in a misinterpretation of the
data as showing deviation from additivity) is
minimized; third, the number of dose levels
to be tested is reduced if high dose combi-
nations are not included.
• Analysis of variance with an interaction
term is a readily available statistical proce-
dure that lends itself to the analysis of the
mixture data obtained within a linear dose
response.
• Results of cellular systems must be inter-
preted with extreme caution. They may be
speciﬁc to species, cell type, and agent and
may not be extrapolated to other situations.
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